Skip to main content
The Egyptian Journal of Internal Medicine

Table 8 Agreement for pretreatment Angiopoietin-2 (pg/ml) in discrimination of F4 cirrhosis (n=7) from F0–F3 (n=33)

From: Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs

 

AUC

p

95% CI

Cut off

Sensitivity

Specificity

PPV

NPV

Angiopoietin-2

0.978

<0.001*

0.932–1.024

>630

85.71

84.85

54.5

96.6

  1. *significant
Back to article page